News from seqirus
A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages
26 Aug, 2016, 17:21 BST Seqirus presents analysis reinforcing the safety and immunogenicity profiles of its MF59®-adjuvanted seasonal trivalent influenza vaccine in adults 65 years and older
NOTE TO EDITORS: The influenza vaccines business, previously owned by Novartis, has been integrated into CSL's influenza vaccine business and now...